Banque Cantonale Vaudoise raised its holdings in shares of MetLife, Inc. (NYSE:MET – Free Report) by 426.4% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 51,374 shares of the financial services provider’s stock after acquiring an additional 41,615 shares during the period. Banque Cantonale Vaudoise’s holdings in MetLife were worth $4,237,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently modified their holdings of the company. MeadowBrook Investment Advisors LLC boosted its holdings in MetLife by 244.4% during the 3rd quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 220 shares during the period. Carmichael Hill & Associates Inc. lifted its position in MetLife by 131.9% in the third quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 186 shares during the last quarter. Wolff Wiese Magana LLC lifted its position in MetLife by 374.3% in the third quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock valued at $29,000 after purchasing an additional 277 shares during the last quarter. Peterson Financial Group Inc. bought a new position in shares of MetLife in the third quarter worth approximately $30,000. Finally, Fortitude Family Office LLC increased its stake in shares of MetLife by 177.3% in the third quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider’s stock worth $34,000 after buying an additional 266 shares during the period. 89.81% of the stock is owned by institutional investors.
MetLife Price Performance
Shares of MET stock opened at $82.60 on Wednesday. The business’s fifty day moving average is $81.92 and its 200 day moving average is $75.80. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.51. The stock has a market cap of $57.19 billion, a price-to-earnings ratio of 16.65, a PEG ratio of 0.76 and a beta of 1.05. MetLife, Inc. has a twelve month low of $61.85 and a twelve month high of $86.94.
MetLife Announces Dividend
Wall Street Analyst Weigh In
Several brokerages have weighed in on MET. TD Cowen assumed coverage on shares of MetLife in a research report on Wednesday, October 9th. They set a “buy” rating and a $97.00 price target for the company. Bank of America dropped their target price on shares of MetLife from $99.00 to $96.00 and set a “buy” rating for the company in a report on Thursday, August 1st. Morgan Stanley reduced their price target on MetLife from $86.00 to $85.00 and set an “overweight” rating on the stock in a report on Monday, August 19th. Barclays dropped their price objective on MetLife from $91.00 to $90.00 and set an “overweight” rating for the company in a report on Thursday, October 31st. Finally, Citigroup lifted their price objective on MetLife from $83.00 to $89.00 and gave the stock a “buy” rating in a research report on Tuesday, July 23rd. Fourteen analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $88.46.
View Our Latest Research Report on MetLife
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Further Reading
- Five stocks we like better than MetLife
- When to Sell a Stock for Profit or Loss
- Super Micro Computer Soars 28%: Is It Really Out of the Woods?
- What Do S&P 500 Stocks Tell Investors About the Market?
- Traders Are Flocking Back to Oil: What’s Fueling the Optimism
- What is Short Interest? How to Use It
- 3 Hot Stock Trends to Ride Into 2025
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.